The global HPV testing market is expected to grow at a CAGR of 5.5% from 2021 to 2030. The growth of the market can be attributed to the increasing number of cervical cancer cases and rising awareness about HPV infection. The cervical cancer screening segment is expected to dominate the market during the forecast period, due to its high prevalence in women and increasing awareness about HPV infection.
The global HPV testing market is segmented by type, application, and region. On the basis of type, it is classified into HPV testing and Folloup HPV Testing. On the basis of application, it is classified into cervical cancer screening and vaginal cancer screening. On the basis of region, it is classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA). In terms of geography, NA accounted for a major share in 2018 owing to its high prevalence rate in women as well as increased awareness about sexually transmitted diseases such as HIV/AIDS among people living in this region. APAC has been witnessing significant growth owing to rising awareness about sexually transmitted diseases such as HIV/AIDS among people living in this region coupled with an increase in disposable income levels which has led them towards adopting preventive measures against these infections including vaccination against human papillomavirus or vaccination against human papillomavirus infection which are both available at affordable prices across this region.
Some Of The Growth Factors Of This Market:
- The HPV vaccine is not recommended for children under the age of 11, so there is a need for other methods to prevent HPV infection in this population.
- The incidence of HPV-related cancers has increased over the past few decades, and it is estimated that by 2020, there will be more than 500,000 new cases of cancer caused by HPV each year worldwide.
- There are many different types of HPV and some are more likely to cause cancer than others; however, most people who have an infection with any type of HPV do not develop cancer or any other symptoms from the virus.
- In addition to cervical cancer screening with Pap tests or liquid-based cytology (LBC), women can also be screened for high-risk types of human papillomavirus (HPV) using a test called an "HPV DNA test.".
- A recent study found that women who had been vaccinated against human papillomavirus were less likely to have abnormal cells on their cervixes than those who had not been vaccinated.
Industry Growth Insights published a new data on “HPV Testing Market”. The research report is titled “HPV Testing Market research by Types (HPV Testing, Follow-up HPV Testing, Co-testing), By Applications (Cervical Cancer Screening, Vaginal Cancer Screening, Other), By Players/Companies Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
HPV Testing Market Research Report
By Type
HPV Testing, Follow-up HPV Testing, Co-testing
By Application
Cervical Cancer Screening, Vaginal Cancer Screening, Other
By Companies
Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global HPV Testing Market Report Segments:
The global HPV Testing market is segmented on the basis of:
Types
HPV Testing, Follow-up HPV Testing, Co-testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cervical Cancer Screening, Vaginal Cancer Screening, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qiagen
- Roche Diagnostics
- Hologic
- Abbott Laboratories
- BD
- Seegene, Inc.
Highlights of The HPV Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HPV Testing
- Follow-up HPV Testing
- Co-testing
- By Application:
- Cervical Cancer Screening
- Vaginal Cancer Screening
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HPV Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HPV testing is a way to determine if you have HPV, which can cause cervical cancer.
Some of the major players in the hpv testing market are Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc..
The hpv testing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. HPV Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HPV Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HPV Testing Market - Supply Chain
4.5. Global HPV Testing Market Forecast
4.5.1. HPV Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HPV Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. HPV Testing Market Absolute $ Opportunity
5. Global HPV Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. HPV Testing Market Size and Volume Forecast by Type
5.3.1. HPV Testing
5.3.2. Follow-up HPV Testing
5.3.3. Co-testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global HPV Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. HPV Testing Market Size and Volume Forecast by Application
6.3.1. Cervical Cancer Screening
6.3.2. Vaginal Cancer Screening
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global HPV Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. HPV Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global HPV Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. HPV Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global HPV Testing Demand Share Forecast, 2019-2029
9. North America HPV Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America HPV Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America HPV Testing Market Size and Volume Forecast by Application
9.4.1. Cervical Cancer Screening
9.4.2. Vaginal Cancer Screening
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America HPV Testing Market Size and Volume Forecast by Type
9.7.1. HPV Testing
9.7.2. Follow-up HPV Testing
9.7.3. Co-testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America HPV Testing Demand Share Forecast, 2019-2029
10. Latin America HPV Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America HPV Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America HPV Testing Market Size and Volume Forecast by Application
10.4.1. Cervical Cancer Screening
10.4.2. Vaginal Cancer Screening
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America HPV Testing Market Size and Volume Forecast by Type
10.7.1. HPV Testing
10.7.2. Follow-up HPV Testing
10.7.3. Co-testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America HPV Testing Demand Share Forecast, 2019-2029
11. Europe HPV Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe HPV Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe HPV Testing Market Size and Volume Forecast by Application
11.4.1. Cervical Cancer Screening
11.4.2. Vaginal Cancer Screening
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe HPV Testing Market Size and Volume Forecast by Type
11.7.1. HPV Testing
11.7.2. Follow-up HPV Testing
11.7.3. Co-testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe HPV Testing Demand Share, 2019-2029
12. Asia Pacific HPV Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific HPV Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific HPV Testing Market Size and Volume Forecast by Application
12.4.1. Cervical Cancer Screening
12.4.2. Vaginal Cancer Screening
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific HPV Testing Market Size and Volume Forecast by Type
12.7.1. HPV Testing
12.7.2. Follow-up HPV Testing
12.7.3. Co-testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific HPV Testing Demand Share, 2019-2029
13. Middle East & Africa HPV Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa HPV Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa HPV Testing Market Size and Volume Forecast by Application
13.4.1. Cervical Cancer Screening
13.4.2. Vaginal Cancer Screening
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa HPV Testing Market Size and Volume Forecast by Type
13.7.1. HPV Testing
13.7.2. Follow-up HPV Testing
13.7.3. Co-testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa HPV Testing Demand Share, 2019-2029
14. Competition Landscape
14.1. Global HPV Testing Market: Market Share Analysis
14.2. HPV Testing Distributors and Customers
14.3. HPV Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Qiagen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hologic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Seegene, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
